An analysis from the Kaiser Family Foundation of the 2017 financial performance of health insurers found that last year was their best year selling individual-market health insurance since the Affordable Care Act was put into place, even without the cost-sharing subsidies that they lost in the fourth quarter.
An analysis from the Kaiser Family Foundation (KFF) of the 2017 financial performance of health insurers found that last year was their best year selling individual-market health insurance since the Affordable Care Act (ACA) was put into place, even without the cost-sharing subsidies that they lost in the fourth quarter.
The findings suggest that insurers, on average, priced their plans adequately last year, the report said. The analysis is based on insurer-reported financial data, including information from the National Association of Insurance Commissioners.
KFF used 2 different financial indicators to come up with their findings:
In addition, premiums per enrollee grew 22% from 2016 to 2017, while per person claims grew only 5%, further helping profitability.
The ACA required insurers to guarantee access to coverage for patients with pre-existing conditions and cover those conditions in the early years of the law in 2014 and 2015. Previously, before the ACA, insurers could excude coverage and services for people with pre-existing conditions, which was a less expensive way of doing business.
KFF said 2018 and 2019 presents new challenges, given changes made during recent months by the Trump administration, including:
KFF said these changes and political uncertainties are driving up premiums and potentially pricing out healthy consumers.
It is likely that insurers would generally have required only modest premium increases in 2018 and in 2019 as well if the administration had not made these changes, KFF claimed. Insurers are looking to file proposed rates for 2019, and in some parts of the country, individual markets are fragile, with little competition and an insufficient number of healthy enrollees to balance out the unhealthy.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen